Applications of 5-Phenylhydantoin in Industrial Manufacturing

5-Phenylhydantoin serves as a key building block in several specialized manufacturing sectors, predominantly in pharmaceuticals, fine chemical synthesis, and certain diagnostic reagent applications. As an original chemical raw material producer, we ensure strict batch-to-batch consistency to meet the advanced requirements of downstream processors worldwide. The following application scenarios present how our material supports precise formulation, tight regulatory compliance, and controlled integration into diverse industrial processes.

1. Active Pharmaceutical Intermediate for Antiepileptic Drug Synthesis

5-Phenylhydantoin acts as a direct intermediate in the manufacture of phenytoin, a widely prescribed anticonvulsant. Selected pharmaceutical producers utilize this compound under rigorous quality assurance guidelines to ensure reproducibility in drug synthesis and compliance with regulatory demands at commercial scale.

Industry compliance standards

• ICH Q7 Good Manufacturing Practice for Active Pharmaceutical Ingredients
• USP Monograph for Phenytoin (for API batch consistency)
• European Pharmacopoeia (Ph. Eur.) for starting materials
• 21 CFR Part 211 (U.S. FDA CGMP for finished pharmaceuticals)

Typical usage ratio

• Stoichiometric proportion as per reaction scheme: typically 1.0–1.1 molar equivalents per batch of phenytoin synthesis; minor adjustments made based on yield optimization and scale.

Downstream process integration

• Introduced during the primary condensation reaction with urea and benzil, forming the hydantoin core structure, followed by subsequent cyclization and purification steps.

Final product types

• Phenytoin active pharmaceutical ingredient (API)
• Tablet, capsule, and injectable dosage forms for antiepileptic therapy

2. Precursor in the Synthesis of Dipeptide-Based Peptidomimetics

Researchers and fine chemical manufacturers apply 5-Phenylhydantoin as a protected amino acid mimic, enabling the assembly of custom dipeptide and peptidomimetic structures. This application targets high-value medicinal chemistry programs and combinatorial peptide libraries.

Industry compliance standards

• ISO 9001:2015 Quality Management Systems in chemical synthesis
• REACH (EC 1907/2006) substance registrations, where applicable
• GLP principles for research intermediates
• Supplier material traceability documentation

Typical usage ratio

• 0.8–1.5 molar equivalents per dipeptide coupling step; adjusted according to targeted chain length and protection group strategies.

Downstream process integration

• Employed at the initial coupling or elongation stage of solid-phase peptide synthesis, especially for building non-proteinogenic phenylated residues before N- or C-terminal deprotection.

Final product types

• Peptidomimetic pharmaceuticals for clinical research
• Diagnostic peptide substrates
• Structure-activity relationship (SAR) library compounds

3. Analytical Reagents in Amino Acid Quantification Protocols

Diagnostic kit manufacturers integrate 5-Phenylhydantoin as a derivatizing agent in the Edman degradation process for N-terminal sequencing of peptides. Quality requirements demand high purity and minimal side-product formation to ensure accuracy in analytical workflows within certified laboratories.

Industry compliance standards

• ISO 13485:2016 for medical device quality systems (diagnostic reagents)
• CLSI guidelines for laboratory reagent validation
• CE Marking for EU-marketed diagnostics
• FDA 21 CFR 820 for US device compliance

Typical usage ratio

• Applied in equimolar or slight excess (1.0–1.3 equivalents) relative to peptide substrate concentration in reaction vials for sequential identification steps.

Downstream process integration

• Directly enters the amino acid sequencing step within pre-loaded columns or microplate-based analytic platforms, following cleavage and extraction processes.

Final product types

• Clinical amino acid analysis kits
• Research-grade sequencing reagent packs
• Automated peptide sequencer columns

4. Intermediate for Agrochemical Synthesis (Herbicide Research Compounds)

Specialty agrochemical companies employ 5-Phenylhydantoin as a precursor in tailored heterocyclic synthesis, supporting herbicide candidate development. Consistent supply ensures reliable integration into multi-step synthesis, critical for discovery and early pilot trials under strict regulatory frameworks.

Industry compliance standards

• OECD Good Laboratory Practice for chemical development
• ISO 9001:2015 for agrochemical intermediates
• EU Regulation (EC) No 1107/2009 on plant protection products
• EPA FIFRA (40 CFR Part 158) for US agrochemical registrations

Typical usage ratio

• Ranged at 1.0 equivalent per targeted heterocyclic ring-forming reaction, with minor variation (0.95–1.1 equivalent) for yield or purity optimization across series.

Downstream process integration

• Incorporated at the stage of nitrogen heterocycle assembly, antecedent to halogenation or functional group addition steps forming bioactive moieties for test formulations.

Final product types

• Candidate herbicide compounds (pilot batch stage)
• Analytical reference substances for field and residue studies